Feature Channels: Pharmaceuticals

Filters close
Released: 12-Mar-2020 9:30 AM EDT
Rapid Diagnosis Test for Coronavirus COVID-19 Now Available
Surgisphere Corporation

Surgisphere Corporation announces the availability of a rapid diagnostic tool for novel coronavirus.

   
Released: 12-Mar-2020 9:00 AM EDT
Coriell Life Sciences to Provide Coronavirus COVID-19 Reporting to Laboratories
Coriell Life Sciences

Coriell Life Sciences (CLS), a leading provider of molecular test interpretation and reporting, is offering its coronavirus analysis and reporting services to laboratories throughout the United States at no cost during this period of public health crisis.

   
Released: 12-Mar-2020 8:00 AM EDT
Statins Starve Cancer Cells to Death
Johns Hopkins Medicine

More than 35 million Americans take statin drugs daily to lower their blood cholesterol levels. Now, in experiments with human cells in the laboratory, researchers at Johns Hopkins Medicine have added to growing evidence that the ubiquitous drug may kill cancer cells and have uncovered clues to how they do it.

Released: 11-Mar-2020 4:20 PM EDT
People want more compensation, security for their genomic data
Cornell University

Genomic data donated by the public is valuable for the companies that collect it. But a recent survey finds that once people are aware of issues surrounding the use and security of genetic information, people are more concerned about how it might be used and expect to be better compensated for providing it.

   
9-Mar-2020 8:00 AM EDT
Giving Commonly Used Muscle Relaxant Through Nose Shows Potential to Treat Neurodegenerative Diseases
Perelman School of Medicine at the University of Pennsylvania

Delivering the medication dantrolene through the nose rather than the mouth may help the medication penetrate the brain more effectively, potentially maximizing its therapeutic benefits in the treatment of neurodegenerative diseases, like Alzheimer’s disease.

Released: 10-Mar-2020 5:45 PM EDT
Cancerous tumors, surrounding cells illuminated by new imaging agent
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have developed a new imaging agent that could let doctors identify not only multiple types of tumors but the surrounding normal cells that the cancer takes over and uses as a shield to protect itself from attempts to destroy it.

6-Mar-2020 8:15 AM EST
St. Jude finds cancer drug resistance genes and possibly how to limit their effects
St. Jude Children's Research Hospital

Drug resistance is a leading cause of cancer death in children and adults with leukemia. St. Jude Children’s Research Hospital scientists have developed a novel strategy to find the genes responsible.

6-Mar-2020 8:10 AM EST
Microscopic STAR Particles Offer New Potential Treatment for Skin Diseases
Georgia Institute of Technology

In a study to be published in the journal Nature Medicine, researchers report on using a skin cream infused with microscopic particles, named STAR particles, to potentially facilitate better treatment of skin diseases including psoriasis, warts, and certain types of skin cancer.

Released: 6-Mar-2020 2:25 PM EST
New Imaging Technique Enables the Study of 3D Printed Brain Tumors
Rensselaer Polytechnic Institute (RPI)

In research published in Science Advances, Xavier Intes, a professor of biomedical engineering at Rensselaer, joined a multidisciplinary team from Northeastern University and the Icahn School of Medicine at Mount Sinai to demonstrate a methodology that combines the bioprinting and imaging of glioblastoma cells in a cost-effective way that more closely models what happens inside the human body.

   
Released: 6-Mar-2020 8:00 AM EST
Mount Sinai and Harbour BioMed Collaborate to Advance Novel Biotherapies for the Treatment of Cancer and Coronavirus COVID-19
Mount Sinai Health System

Collaboration combines Harbour BioMed’s proprietary H2L2 Harbour Mice® platform for fully human monoclonal antibody generation with Mount Sinai’s translational medical research expertise.

Released: 5-Mar-2020 4:15 PM EST
New drug shows promise for treatment of cancer and other diseases
Creighton University

In the study, a group of lab mice that had consumed a diet that included the HM-10/10 peptide was found to have a significantly lower tumor load than mice that had not eaten the peptide.

2-Mar-2020 1:30 PM EST
The Search for a Biological Link between Reactivated HSV and Neurological Disease
Cincinnati Children's Hospital Medical Center

New research data in the journal PLoS Pathogens suggests that reactivated HSV in trigeminal nerves of laboratory mice kills off at least a portion of sensory neurons. The findings provide additional evidence that as humans get older, the long-term consequences of HSV infection in the nervous system can accumulate and cause neurological damage.

4-Mar-2020 6:05 PM EST
Combination of engineered cold sore virus and inhibitor drugs could destroy brain tumors
University of Texas Health Science Center at Houston

Researchers who discovered that an engineered cold sore virus could help destroy brain tumors from the inside out have determined a one-two punch might be the key to finish them off. This virotherapy could make a class of investigational cancer drugs more effective, according to investigators at UTHealth.

Released: 5-Mar-2020 9:40 AM EST
Vinyl Chloride, Nerve Growth Factor, Chemical Warfare, and More Examined in March 2020 Toxicological Sciences
Society of Toxicology

The March 2020 issue of Toxicological Sciences features leading research in toxicology, covering investigations in biotransformation, toxicokinetics, and pharmacokinetics in addition to work in exposure sciences and environmental toxicology.

   
Released: 5-Mar-2020 8:10 AM EST
Researchers develop new coating to reduce pain and risk of infection for catheter users
Queen's University Belfast

Researchers from the School of Pharmacy at Queen’s University Belfast have developed a new antimicrobial coating which can be applied to urinary catheters and other medical devices to significantly reduce pain and lower the risk of infection for its users. This unique coating has the potential to greatly improve the quality of life for the millions of catheter users worldwide.

   
Released: 5-Mar-2020 8:05 AM EST
Curcumin is the spice of life when delivered via tiny nanoparticles
University of South Australia

For years, curry lovers have sworn by the anti-inflammatory properties of turmeric, but its active compound, curcumin, has long frustrated scientists hoping to validate these claims with clinical studies.

   
Released: 4-Mar-2020 4:40 PM EST
New funding to support male contraception studies
Cornell University

Most birth control options rely on women to manage, but promising Cornell research from the lab of Paula Cohen may be changing the game by tackling male contraception.

28-Feb-2020 6:25 PM EST
Study: Smartphone Users with Headache May Use More Medication and Find Less Relief
American Academy of Neurology (AAN)

People with headache who use smartphones may be more likely to use more pain medication and find less relief when they do than people with headache who do not use smartphones, according to a preliminary study published in the March 4, 2020, online issue of Neurology® Clinical Practice, an official journal of the American Academy of Neurology. The study does not prove that smartphone use causes greater use of pain medication and less relief; it only shows an association.

   
Released: 4-Mar-2020 3:55 PM EST
The Medical Minute: New treatments for migraines show promise
Penn State Health

Many people think migraines are just bad headaches – but they’re so much more. While no cure for migraines exists, hope abounds thanks to major advances in research.

Released: 4-Mar-2020 3:05 PM EST
Coronavirus treatment and risk to breastfeeding women
Mary Ann Liebert

Little data is available about the ability of antiviral drugs used to treat COVID-19, coronavirus, to enter breastmilk, let alone the potential adverse effects on breastfeeding infants.



close
3.21149